Intra Cellular Therapies shares owned by UBS Group
Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Intra Cellular Therapies
Tip: Access up to 7 years of quarterly data
All positions including Intra Cellular Therapies held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intra Cellular Therapies by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $6.1M | 74k | 83.52 |
| 2024-09-30 | $4.1M | 56k | 73.17 |
| 2024-06-30 | $3.2M | 47k | 68.49 |
| 2024-03-31 | $9.5M | 137k | 69.20 |
| 2023-12-31 | $9.7M | 135k | 71.62 |
| 2023-09-30 | $2.3M | 44k | 52.09 |
| 2023-06-30 | $4.7M | 75k | 63.32 |
| 2023-03-31 | $2.2M | 40k | 54.15 |
| 2022-12-31 | $1.5M | 29k | 52.92 |
| 2022-09-30 | $121k | 2.6k | 46.43 |
| 2022-06-30 | $203k | 3.5k | 57.20 |
| 2022-03-31 | $3.8M | 61k | 61.32 |
| 2021-12-31 | $2.1M | 40k | 52.16 |
| 2021-09-30 | $125k | 3.4k | 37.31 |
| 2021-06-30 | $530k | 13k | 40.88 |
| 2021-03-31 | $661k | 20k | 33.95 |
| 2020-12-31 | $621k | 20k | 31.72 |
| 2020-09-30 | $108k | 4.2k | 25.71 |
| 2020-06-30 | $510k | 20k | 25.22 |
| 2020-03-31 | $769k | 50k | 15.37 |
| 2019-12-31 | $2.5M | 73k | 34.37 |
| 2019-09-30 | $53k | 7.1k | 7.46 |
| 2019-06-30 | $109k | 8.4k | 12.98 |
| 2019-03-31 | $147k | 12k | 12.32 |
| 2018-12-31 | $103k | 9.1k | 11.28 |
| 2018-09-30 | $13k | 600 | 21.67 |
| 2018-06-30 | $14k | 768 | 17.86 |
| 2018-03-31 | $42k | 2.0k | 21.25 |
| 2017-12-31 | $9.0k | 600 | 15.00 |
| 2017-09-30 | $177k | 11k | 15.84 |
| 2017-06-30 | $176k | 14k | 12.39 |
| 2017-03-31 | $2.0k | 100 | 20.00 |
| 2016-12-31 | $2.0k | 100 | 20.00 |
| 2016-09-30 | $93k | 6.1k | 15.29 |
| 2016-06-30 | $802k | 21k | 38.33 |
| 2016-03-31 | $24k | 800 | 30.00 |
| 2015-12-31 | $100k | 1.8k | 54.14 |
| 2015-09-30 | $16k | 400 | 40.00 |
| 2015-03-31 | $25k | 998 | 25.00 |